BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16156346)

  • 1. Statin therapy in patients with type 2 diabetes.
    Lo V; Noviasky J; Nashelsky J
    Am Fam Physician; 2005 Sep; 72(5):866-8. PubMed ID: 16156346
    [No Abstract]   [Full Text] [Related]  

  • 2. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
    Kwan BC; Beddhu S; Kronenberg F; Cheung AK
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):76-7. PubMed ID: 16932397
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH
    Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
    Betteridge J
    Am J Med; 2005 Dec; 118 Suppl 12A():10-5. PubMed ID: 16356802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.
    Mills EJ; Wu P; Chong G; Ghement I; Singh S; Akl EA; Eyawo O; Guyatt G; Berwanger O; Briel M
    QJM; 2011 Feb; 104(2):109-24. PubMed ID: 20934984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive cholesterol-lowering treatment in type 2 diabetes mellitus: an update.
    Delport R
    Cardiovasc J S Afr; 2004; 15(4):195-6. PubMed ID: 15322580
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing the start time of statin therapy for patients with diabetes.
    Denton BT; Kurt M; Shah ND; Bryant SC; Smith SA
    Med Decis Making; 2009; 29(3):351-67. PubMed ID: 19429836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?].
    Albert Fàbregas L; González-Clemente JM
    Med Clin (Barc); 2014 Apr; 142(8):358-9. PubMed ID: 24602748
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins as cardioprotective agents.
    Piskur JR; Stone NJ
    Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
    Båvenholm P; Attvall S; Nilsson PM
    Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins and risk of new-onset diabetes mellitus.
    Shah RV; Goldfine AB
    Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Low carbohydrate diets reduce the need of statin treatment].
    Ravnskov U
    Lakartidningen; 2006 Oct 4-10; 103(40):3017; author reply 3017-8. PubMed ID: 17115674
    [No Abstract]   [Full Text] [Related]  

  • 15. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.
    Weymiller AJ; Montori VM; Jones LA; Gafni A; Guyatt GH; Bryant SC; Christianson TJ; Mullan RJ; Smith SA
    Arch Intern Med; 2007 May; 167(10):1076-82. PubMed ID: 17533211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH
    Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do people with diabetes need statins?
    White JR
    Diabetes Educ; 2008; 34(4):664-73. PubMed ID: 18669808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus].
    Ruiz J; Egli M
    Rev Med Suisse; 2006 May; 2(68):1480-2, 1484-5. PubMed ID: 16783994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.